On the recordNovember 29, 2011
None of the reasons that the FDA cites are due to pricing issues, and certainly none of them are related to 340(b).
Source
congress.govNone of the reasons that the FDA cites are due to pricing issues, and certainly none of them are related to 340(b).
Murphy asserts that pricing is not a cause of drug shortages according to the FDA.
Share
More from Chris Murphy
From top to bottom, these ATF rule changes are all about making sure Trump’s gun industry donors can maximize their profits by ignoring the popular, common sense regulations that prevent gun crime and save lives.
The supposed deal that’s on the table right now would pay Iran $100 million, excuse me, $100 billion a year, in order to reopen the Strait.
These cuts would strip disabled veterans of earned compensation and health care benefits – they should be rejected outright.
Weighing that against the boost for Ukraine, I think it’s important to support Ukraine right now.